top of page
shutterstock Brain scan image
Broadreach Global logo white

SHARE

  • LinkedIn
  • Twitter
TNS LOGO Transparent

THE NEURO SUMMIT

Digital Health, NeuroTech, MedTech, DeepTech, Data & A.I.

Broadreach Global logo white

Oct. 11 - 13

2023

Champalimaud Foundation,

Lisbon, Portugal

Innovation & Partnering at the confluence of Neuroscience and Mental Health with Digital Health, MedTech, DeepTech, Data & Artificial Intelligence.

Welcome
About
Champalimaud Foundation exterior reflecting pool
ABOUT
Insight - Innovation - Access - Engagement - Partnering

The one summit which convenes a high level, by-invitation, boutique
gathering of key thought leaders, innovators and decision-makers from all key stakeholder groups in digital health, tech and A.I. for neurosciences and mental health.  Addressing not only opportunities but also the core challenges facing companies and stakeholders. Sharing models, lessons learned, mistakes, solutions, ways forward and best practices. Fostering a unique level of sustained high-quality discussion, access, engagement and partnering in a truly curated  summit unlike any other event. 

 
Champalimaud Foundation Auditorium entrance
VISION

Convening the full value chain to disrupt silos and curate highly interactive, multi-disciplinary, cross-industry, and multi-stakeholder discussions of opportunities, challenges, hurdles and ways forward.

 

Drive transformational connections, discussion and partnering for startups and growth companies. 

 

Deliver insight, access, engagement and partnering to foster innovation and accelerate value creation.

 

Contribute to meaningful improvement in healthcare outcomes and positive impact for patients and society.  

Champalimaud Foundation Exterior 1
WHY NOW?

From A.I. enabled drug discovery and development, big data, digital biomarkers, Real World Data and trial design, to advanced imaging, companion digital health, cognitive behavioral therapy and connected health, to neuromodulation and V.R., the pace of innovation is unprecedented.

 

Paradigms are changing, and the potential for positive impact on patient outcomes and quality of life, improved delivery of care, healthcare expenditure, and societal benefit are enormous.

The Neuro, Digital & A.I. Innovation Summit is organized by Broadreach Global and Hosted by the Champalimaud Foundation, with Partners the European Brain Council (EBC), and the support of our Global Innovation Partners and other key stakeholder organizations.

 

The launch edition in 2022 delivered  a unique, meaningful and high-impact initiative unlike other events. Join us in 2023.

Company presentation Image by Carlos Gil
PRESENTING COMPANIES

Join a curated selection of the best, world-class , innovative  neuro and mental health companies in Digital, MedTech, DeepTech, Data & A.I. with potential to transform healthcare, patient outcomes or markets.  Selection is by excellence and potential, not by price tag!

There is no cost to present beyond the regular startup or private company registration fees.

Benefit from:

- Pre-summit guidance and feedback on your deck.

- An on-site dry-run presentation with feedback and coaching from expert mentors.

- A3 minute pitch plus 3 minutes of Q&A with an expert panel of relevant investors, industry & experts.

- 2.5 Days of sustained engagement with the best network of innovators, investors, industry leaders & decision-makers in brain health digital, medtech, deeptech & A.I.

Broadreach Summits - What Participants Say

"...Nothing short of incredible. So many brilliant innovators, policymakers, researchers and investors all with the same mission to advance brain health. I was in awe of this groundbreaking growing community and humbled to be invited to take part in it."

Noga Sapir, Founder & CEO -

 Reflect Innovation (Israel)

shutterstock brain scan 3

ADVISORY BOARD

We are honored to introduce our advisory board: meet them in person at the summit.

Joe Paton

Joe Paton

Director of Neuroscience & Principal Investigator, Champalimaud Foundation

Ana Maiques

Ana Maiques

CEO & Co-Founder, Neuroelectrics

Paulo Machado

Paulo Machado

CEO/Founder - Health Innovation Partners, Angel - What if Ventures, Strategic Advisor - Meadows Mental Health Policy Institute

Pawel Swieboda

Pawel Swieboda

Founder - NeuroCentury; Practice Lead Neurotechnology, ICFG; Senior Advisor on Brain Health, FIPRA

Shwen Gwee

Shwen Gwee

Digital Health & Corporate Innovation Executive, ex BMS Global Head of Digital Strategy, ex-Novartis BIOME & Open Innovation co-founder

Mark Treherne

Mark Treherne

Chairperson - Monument Therapeutics. Commercial Scientist, Entrepreneur & Investor. Chairperson of Talisman Therapeutics, Ubiqent, NuVision Biotherapies

Joachim Scholpp

Joachim Scholpp

Global Head Translational Medicine CNS & Emerging Areas, Boehringer Ingelheim, Germany

Naomi Glover

Naomi Glover

Co-Founder/Director, Applied Neuroscience Association

Christian J. Suojanen

Christian J. Suojanen

Founder & CEO - Broadreach Global, Member of the Board - European Brain Foundation (EBF)

Fred Destrebecq

Fred Destrebecq

Executive Director, European Brain Council (EBC)

Advisors

SPEAKERS

Proudly convening leading speakers and stakeholders from across the sector
Speakers
John Krakauer

John Krakauer

Professor of Neurology, Neuroscience, and Physical Medicine & Rehabilitation - Johns Hopkins School of Medicine (Maryland)

Ana Maiques

Ana Maiques

CEO & Co-Founder - Neuroelectrics (Barcelona)

Zenna Tavares

Zenna Tavares

Founder & Director - Basis Research Institute, Research Scientist - Data Science Institute & Innovation Fellow - Zuckerman Mind Brain Behavior Institute - Columbia University, New York

Daniela Pimenta da Silva

Daniela Pimenta da Silva

Neurologist and PhD student - CNS-Campus Neurologico and Faculty of Medicine of the University of Lisbon

Daniel Wetmore

Daniel Wetmore

Senior Research Scientist – Meta Reality Labs, NY, NY

Joe Paton

Joe Paton

Director of Neuroscience & Principal Investigator, Champalimaud Foundation

Joachim Scholpp

Joachim Scholpp

Global Head Translational Medicine CNS & Emerging Areas, Boehringer Ingelheim, Germany

Nick Taptiklis

Nick Taptiklis

Head of Technology Strategy - Cambridge Cognition (UK)

Georgia Mitsi

Georgia Mitsi

Enterpreneur in Residence - Emerald BioVentures (Boston)

Pawel Swieboda

Pawel Swieboda

Founder - NeuroCentury; Practice Lead Neurotechnology, ICFG; Senior Advisor on Brain Health, FIPRA

Ariane Tom, PhD

Ariane Tom, PhD

Founding Partner - Kaleida Capital (San Diego)

David Braga Malta

David Braga Malta

Life Sciences Investor & Entrepreneur - PE Thematic Health, Pictet Bank (Switzerland)

Gilad Peleg

Gilad Peleg

Founding Partner - LifeOne Ventures (Israel)

Paulo Machado

Paulo Machado

CEO/Founder - Health Innovation Partners, Angel - What if Ventures, Strategic Advisor - Meadows Mental Health Policy Institute

Amir Bozorgzadeh

Amir Bozorgzadeh

Co-Founder & CEO - Virtuleap

Bruno Montanari

Bruno Montanari

Partner - Seroba Life Sciences, Paris

Beth Wolf

Beth Wolf

Director Digital Health Solutions, Global Corporate Strategy & BD - Lundbeck, Copenhagen

Mark Treherne

Mark Treherne

Chairperson - Monument Therapeutics. Commercial Scientist, Entrepreneur & Investor. Chairperson of Talisman Therapeutics, Ubiqent, NuVision Biotherapies (UK)

Julia Prakapovich

Julia Prakapovich

Partner - Interface Fund (London)

Dan Mannix

Dan Mannix

CEO - Advisor - Brain Health Investor, former CEO - RWC Partners (UK)

Tiago Marques

Tiago Marques

Senior Research Scientist - Champalimaud Foundation, Chief Technology Office - HEKA vision, Lisbon

Razi Syed

Razi Syed

Head of Product - Sahha

Xavier Louis

Xavier Louis

Co-founder & CEO - Five Lives

Carla Zaldua Aguirre,

Carla Zaldua Aguirre,

Co-Founder & CEO - acceXible

Olivier de Simone

Olivier de Simone

Co-Founder & CEO - Sensae

Dr. Laura Murray

Dr. Laura Murray

Clinical Psychologist, CEO/Founder - CETA Global; Senior Scientist - Johns Hopkins Bloomberg School of Public Health, Entrepreneur, Researcher and Clinician (Maryland)

Joshua Haynes

Joshua Haynes

Founder & Managing Partner - Masawa Fund (Berlin)

Shwen Gwee

Shwen Gwee

Digital Health & Corporate Innovation Executive, ex BMS Global Head of Digital Strategy, ex-Novartis BIOME & Open Innovation co-founder (Boston)

Hossein Jalali

Hossein Jalali

Cofounder & CTO - Virtuleap

Naomi Glover

Naomi Glover

Co-Founder/Director - Applied Neuroscience Association (London)

Hannes Klöpper

Hannes Klöpper

CEO - HelloBetter Co-Chair - European Policy Task Group of the Digital Therapeutics Alliance

Marco Mohwinckel

Marco Mohwinckel

Mental Health Executive & Investor, Chairman – Altibbi, Director - Magnolia Health Advisors (London)

Xavier Palomer Ripoll

Xavier Palomer Ripoll

Founder - Amelia Virtual Care

Amanda Borgerhoff

Amanda Borgerhoff

Vice President Client Services - Warman O'Brien

JP Borges

JP Borges

Managing Partner - JP Borges Abogados, Co-Founder - Exputnik Accelerator (Spain)

Mick Walsh

Mick Walsh

VP Commercial & Business Development - Head Diagnostics (Ireland)

Hana Besbes

Hana Besbes

Investor - Heal Capital (Berlin)

Jason Dictenberg

Jason Dictenberg

Investor, Executive, CEO - AccelBio, Chairman - Evergreen Biosciences, Advisory Board Member - Alzheimer's Drug Discovery Foundation, Editor - CellR4 Journal on Regenerative Medicine (New York)

Richard Stokvis

Richard Stokvis

Managing Director - BOA Healthcare Holdings Limited

Lorena Muñoz Vivas

Lorena Muñoz Vivas

CEO - Effectia Consulting (Spain)

Christian J. Suojanen

Christian J. Suojanen

CEO - Broadreach Global, Member of the Executive Board - European Brain Foundation (USA)

PRESENTING COMPANIES

Head Diagnostics logo
MYOTACT-Logo-HD
BrainTrip logo
NeurOn logo white
Lymbic AI logo
FiveLives logo
Sensae logo
HEKA vision_logo
virtuleap-logo
Participants

WHO'S COMING?

Two days of sustained, interactive discussion, networking and partnering with:

Josch Scholpp speaking

Industry Leaders

Senior industry executives from pharma, digital health, technology & health providers & systems. Heads of therapeutic area, R&D, real world data, clinical development, digital health, scouting, business development & licensing.

Andy Keller keynote 2

Key Opinion Leaders

Key Opinion Leaders from all stakeholder groups at the confluence of neurosciences & mental health with digital, technology, data and A.I.

Speaker background photo

Founders & CEOs

From startup and growth companies at the confluence of  neuroscience and mental health with digital, medtech, imaging, technology, data and A.I.

Government and NGO image

Government & NGOs

Public agencies, societies, associations & NGOs in brain health, neurology, neurosciences, psychiatry & mental health, patient organizations, economic development, health, research & innovation.

Investor Panel BMIS

Investors

In CNS, neuroscience and mental health, data, health tech, digital health, A.I. and deeptech.

VC and corporate venture, private equity, family offices, angels & HNW. 

Strategy image by Karmakar

Leading Advisors

A selected group of leading specialized advisors and consultants with deep subject matter expertise relevant to participants. 

SCHEDULE

The full agenda and program will be shared soon.  In the meantime, here are some general timings, to help you plan your time in Lisbon.  These are for reference only and subject to change as additional sessions and activities are added and final program updates are made.

As always, at The Neuro Summit, all speakers, presenters and participants are encouraged to actively engage and participate throughout, not just in their own sessions.

Oct. 11

14:00 - Registration, Coffee & Networking Open
15:30 - Initial Welcome, Opening Keynote & Panel session
17:30 - End of pre-program - Welcome Networking to 19:15

Oct. 12

08:30 - Registration, Coffee & Networking Open
09:00 - Official Inauguration and Welcome
12:30 - Networking Lunch
17:45 - End of Day II - Networking Reception to 20:00

Oct. 13

08:30 - Registration, Coffee & Networking Open
09:00 - Program Starts
12:45 - End of Summit Program

 

Venue
Chamnpalimaud Skyway image

VENUE

Champalimaud Foundation

Av. Brasília, 1400-038

Lisbon, Portugal

The Champalimaud Foundation carries out research in cutting-edge fields and strives to stimulate discoveries that benefit people, and to promote new standards of knowledge.

It is at the Champalimaud Centre for the Unknown, in Lisbon, that the Foundation develops its activity in the areas of neuroscience and cancer. This is done through both research programmes and the provision of clinical services of excellence. It also has an outreach programme to fight blindness.

To pursue its objectives in achieving significant scientific advances, the Champalimaud Foundation adopts a translational methodology, which establishes a direct link and interdependency between basic research and clinical activity. This is a fundamental part of the Foundation’s methodology.

Ultimately, the Champalimaud Foundation aims to promote the health and well-being of humankind by seeking to actively participate in the search for solutions that can alleviate the burden of disease on societies and individuals.

CO-ORGANIZED WITH

ASSOCIATION PARTNER

HOST PARTNER

The_EBC_logo SMALL
Champalimaud Foundation logo

STRATEGIC PARTNERS & SPONSORS
 

Sponsors

PLATINUM SPONSOR
 

1200px-Boehringer_Ingelheim_Logo

GOLD SPONSOR
 

WOB-logo-portrait

STRATEGIC PARTNERS

Effectia-Logo
JP Borges logo

ASSOCIATION PARTNERS

hbp_logo
Brain Capital Alliance logo
ebrains logo
logo-Amsterdam-Neuroscience
PAREA logo
Round Applied Neuroscience Logo
Enquiries

GET IN TOUCH

Reach us here if you like to

  • Nominate a speaker

  • Apply to present your company or technology

  • Enquire about sponsorship & exhibition opportunities

Thanks, message received. We'll be in touch shortly.

Subscribe

Be the first to know

Subscribe and be among the first to receive all updates, announcements and invitations.

Please make sure to double check your email address.

Thanks for subscribing!

shutterstock brain scan v2

SHARE

  • LinkedIn
  • Twitter

A Broadreach Global Initiative

Contact us at: 

Follow us

Broadreach Global Logo White
Copyright © 2023. All rights reserved. Broadreach Global LLC.
  • LinkedIn
bottom of page